Ligand-specifi ' c activation of HER 4 / pl 80 erbB 4 , a fourth member of the epidermal growth factor receptor family ( receptor tyrosine kne / ERBB 4 gene product )
G. Plowman,J. Culouscou,G. Whitney,Janell M. Green,G. Carlton,L. Foy,M. Neubauer
Abstract:This report describes the isolation and recombmiant expression of a cDNA clone encoding HER4, the fourth member of the human epidermal growth factor receptor (EGFR) family. The HER4/erbB4 gene encodes a 180-kDa transmembrane tyrosine kinase (HER4/p18WbB) whose extraceilular domain is most similar to the orphan receptor HER3/pl6OerbD3, whereas its cytoplasmic kinase domain exhibits 79% and 77% identity withEGFR and HER2/pj85erbB2, respectively. HER4 is most predominaudy expressed in several breast carcinoma cell lines, and in normal skeletal muscle, heart, pituitary, brain, and cerebellum. In addition, we describe the partial purification of a heparin-binding HER4stimulatory factor from HepG2 cells. This protein was found to specifically stimulate the intrinsic tyrosine kinase activity of HER4/plW'rbB4 while having no direct effect on the phosphorylation of EGFR, HER2, or HER3. Furthermore, this heparin-binding protein induces phenotypic differentiation, and tyrosine phosphorylation, of a human mammary tumor cell line that overexpresses both HER4 and HER2. These findings suggest that this ligand-receptor interaction may play a role in the growth and differentiation of some normal and transformed cells. Transmembrane receptors that contain a cytoplasmic tyrosine kinase domain are ofparticular interest to developmental and tumor biologists, since their activation often initiates a cascade of events leading to cell growth and differentiation (1). Included in this group are the receptors for polypeptide growth factors such as epidermal growth factor (EGF), insulin, platelet-derived growth factor, fibroblast growth factor, and neurotrophins. Recently, the ligands for several "orphan" receptors have been identified, including those for c-kit (steel factor), met (hepatocyte growth factor), trk (neurotrophins), and HER2 (heregulin) (1-3). However, numerous receptor tyrosine kinases (RTKs) have been isolated, including eph, eck, elk, ret, and HER3 (1, 4), for which a ligand has not yet been identified. The EGF receptor (EGFR) family is one group of RTKs that is frequently overexpressed in a variety of aggressive epithelial carcinomas and comprises three members: EGFR, HER2/pe85rIbB2, and HER3/pl60erbB3 (4-6). Increased expression of EGFR has been associated with more aggressive cancers of the breast, bladder, lung, and stomach (7); amplification and overexpression of HER2 have been reported for breast and ovarian carcinoma, where high levels ofHER2 directly correlate with a poor clinical prognosis (7, 8); and HER3 expression is amplified in a variety of human adenocarcinomas (9). While several structurally related polypeptides have been identified that specifically bind to the EGFR, including EGF, transforming growth factor a (TGF-a), amphiregulin, heparin-binding EGF, and vaccinia virus growth factor (for review see refs. 7 and 10), none ofthese ligands has been shown to interact with HER2 or HER3. However, several groups have recently reported the identification of candidate ligands for HER2 (2, 3, 11-13). Elucidation of the primary structure of one of these molecules, heregulin/Neu differentiation factor (NDF), reveals it to be an additional member of the EGF family (2, 3). Due to the biolbgical importance of this extended family of ligands and receptors, we have continued our search for additional homologues. This report describes the cloning and expression of a fourth member of the EGFR family, HER4.* MATERIALS AND METHODS Molecular Cloning. Several pools of degenerate oligonucleotides were synthesized on the basis of conserved sequences from EGFR family members. Total genomic DNA was isolated from murine K1735 melanoma cells and used as a template with these oligonucleotide primers in a 40-cycle polymerase chain reaction (PCR) amplification (4). Using the degenerate oligonucleotides H4TVWELM and H4VYMIIL, we identified one clone (MER4-85) that contained a 144-nt insert corresponding to murine erbB4. This 32P-labeled insert was used to isolate a 17-kb fragment from a murine T-cell genomic library (Stratagene) that was found to contain two exons of the murine erbB4 gene. A specific oligonucleotide (4M3070) was synthesized on the basis of the DNA sequence of an erbB4 exon and used in a PCR protocol with a degenerate 5'-oligonucleotide (H4PIKWMA) on a template of single-stranded MDA-MB-453 cDNA. This reaction generated a 260-nt fragment (pMDAPIK) corresponding to human HER4. cDNA libraries were constructed in A ZAP II (Stratagene) from oligo(dT)and specific-primed MDA-MB453 and human heart RNA (4, 10). HER4-specific clones were isolated by probing the libraries with the 32P-labeled insert from pMDAPIK. To complete the cloning ofthe 5' portion of HER4, we used a PCR strategy to allow for rapid amplification of cDNA ends (4). All cDNA clones and several PCRgenerated clones were sequenced on both strands, using T7 polymerase with oligonucleotide primers. The oligonucleotide mixtures (including their degeneracy, corresponding amino acid residues, and orientation) which were used for PCR are as follows: H4TVWELM 5'-ACNGTNTGGGARYTNAYHAC-3' (256-fold, TVWELMT, sense) H4VYMIIL 5'-ACAYTTNARDATDATCATRTANAC-3' (576-fold, VYMIILK, antisense) Abbreviations: EGF, epidermal growth factor; EGFR, EGF receptor; RTK, receptor tyrosine kinase; mAb, monoclonal antibody; TGF-a, transforming growth factor a. *The sequence reported in this paper has been deposited in the GenBank data base (accession no. L07868). 1746 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. D ow nl oa de d by g ue st o n Ju ly 1 5, 2 02 1 Proc. Natl. Acad. Sci. USA 90 (1993) 1747 H4PIKWMA 5'-GACGAATTCCNATHAARTGGATGGC (48-fold, PIKWMA, sense) 4M3070 5'-CTGCTGTCAGCATCGATCAT-3' (antisense). Degenerate residues are: D = A, G, or T; H = A, C, or T; N = A, C, G, or T; R = A or G; and Y = C or T. Assays of Tyrosine Kinase Stimulatory Activity. A panel of four recombinant cell lines, each of which expresses only a single member of the human EGFR family, was generated. The complete 4-kb HER4 coding sequence was reconstructed and inserted into a glutamine synthetase expression vector, pEE14 (14). The resulting construct (pEE14HER4) was transfected into CHO-KI cells, and a stable cell line (CHO/ HER4 #3) expressing high levels of recombinant human p180erbB4 was selected by immunoblotting solubilized cell extracts with a sheep polyclonal antipeptide antibody against HER2 residues 929-947 (Cambridge Research Biochemicals, Valley Stream, NY). CHO/HER2 cells (clone 1-2500) were selected to express high levels of recombinant human p185eItB2 by dihydrofolate reductase-induced gene amplification in dhfr-deficient CHO cells. NRHER5 cells (15) expressing =106 human EGFRs per cell were obtained from Hsing-Jien Kung (Case Western Reserve University, Cleveland). 293/HER3 cells were selected to express high levels of human p160erbB3 (16). Cells were allowed to attach in six-well tissue culture plates (Falcon) at 37°C for 18-24 hr and then incubated in serumfree medium for at least 1 hr prior to addition of the indicated amounts of ligand preparations. After treatment with ligand for 10 min at room temperature, cells were solubilized (17) and the cleared supernatants were allowed to react with 1 iLg of murine monoclonal antibody (mAb) to phosphotyrosine (PY20, ICN) for CHO/HER4 and 293/HER3 cells, or 1 ,ug of murine mAb to HER2 (Neu-Ab3, Oncogene Sciences, Manhasset, NY) for CHO/HER2 cells, or 1 ,ug of mouse mAb Rl to the human EGFR (Amersham) for NRHER5 cells. Antimouse IgG-agarose (for PY20 and Neu-Ab3 mAbs) or staphylococcal protein A-Sepharose (for EGFR-R1 mAb) was used to precipitate the immune complexes. Proteins were separated by SDS/7% PAGE and analyzed by immunoblotting with PY20 mAb essentially as described (12), except phosphoproteins were detected with 125I-labeled goat antimouse IgG F(ab')2 and exposure on a Molecular Dynamics phosphorimager. Cell Differentiation Assay. MDA-MB-453 cells (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum and 1 x essential amino acids. Cells (7500 per well) were allowed to adhere to 96-well plates for 24 hr. Samples were diluted in the above medium and added to the cell monolayer in 50 ul final volume, and the incubation was continued for an additional 3 days. Cells were then examined by inverted light microscopy for morphologic changes. Protein Purification. HepG2 cells (ATCC) were cultured in DMEM containing 10% fetal bovine serum. Ten liters of serum-free conditioned medium (HepG2-CM) was cleared by centrifugation, concentrated 16-fold by using an Amicon ultrafiltration unit (10,000 molecular weight cutoff), and precipitated with 2 M ammonium sulfate. The supernatant was dialyzed against phosphate-buffered saline (PBS) and passed through a DEAE-Sepharose (Pharmacia) column. The flow-through fraction was then applied onto a 4-ml heparinacrylic (Bio-Rad) column. The MDA-MB-453 cell differentiation assay was used throughout the purification procedure to monitor the column fractions. Active fractions, which eluted from the heparin column between 0.4 and 0.8 M NaCl, were precipitated with 2.0 M ammonium sulfate, and the resulting supernatant was loaded onto a phenyl-5PW column (8 x 75 mm, Waters). Bound proteins were eluted by using a 2.0-0.0 M ammonium sulfate gradient in 0.1 M Na2HPO4, pH 7.4. Dialyzed fractions were assayed for tyrosine phosphorylation of MDA-MB-453 cells, essentially as described (2).